Andrew is an associate director of chemistry at Sygnature Discovery with over 16 years' experience within industry as a medicinal chemist. He has worked with and led multi-disciplinary teams that have delivered 3 clinical candidates in fields of oncology, cardiovascular and respiratory diseases. He is a named inventor on 20 patent applications and author of 11 publications. Andrew earnt both his MSci and PhD in synthetic organic chemistry from the University of Nottingham, UK.